Jenoptik Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Jenoptik heeft een totaal eigen vermogen van €1.0B en een totale schuld van €394.2M, wat de schuld-eigenvermogensverhouding op 38.2% brengt. De totale activa en totale passiva bedragen respectievelijk €1.7B en €675.3M. De EBIT Jenoptik is €124.4M waardoor de rentedekking 5.9 is. Het heeft contanten en kortetermijnbeleggingen van €84.2M.
Belangrijke informatie
38.25%
Verhouding schuld/eigen vermogen
€394.25m
Schuld
| Rente dekkingsratio | 5.9x |
| Contant | €84.25m |
| Aandelen | €1.03b |
| Totaal verplichtingen | €675.26m |
| Totaal activa | €1.71b |
Recente financiële gezondheidsupdates
Analyseartikel • Feb 14
We Think Jenoptik (ETR:JEN) Is Taking Some Risk With Its Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analyseartikel • Jul 23
Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analyseartikel • Jan 13
Here's Why Jenoptik (ETR:JEN) Can Manage Its Debt Responsibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyseartikel • May 30
Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Analyseartikel • Dec 20
Is Jenoptik (ETR:JEN) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyseartikel • Jul 25
Jenoptik (ETR:JEN) Has A Pretty Healthy Balance Sheet
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Recent updates
Narratiefupdate • May 06
JEN: Fair Value View Will Hinge On Mixed P/E And Margin Expectations
Analysts have raised the fair value estimate for Jenoptik from €28.50 to approximately €34.81, reflecting updated assumptions on revenue growth, profit margins, and future P/E, along with recent mixed rating and price target revisions from several banks. Analyst Commentary Bullish Takeaways Bullish analysts have raised price targets for Jenoptik, which points to greater confidence in the company’s ability to support a higher fair value over time if it executes as expected.
Narratiefupdate • Apr 21
JEN: Future Returns Will Depend On Execution Against Higher P E Assumptions
Analysts have raised their price targets on Jenoptik by €1 to €6, citing slightly adjusted assumptions for revenue growth, profit margins and future P/E multiples as the key factors behind the revised estimates. Analyst Commentary Recent research updates on Jenoptik point to a mixed backdrop, with higher price targets and rating upgrades sitting alongside more cautious voices that are focused on execution risk and valuation sensitivity.Narratiefupdate • Apr 06
JEN: Future Returns Will Depend On Cautious P/E Assumptions Despite Recent Upgrade
Analysts have nudged their Jenoptik price targets higher, with recent increases of €1 and €6. These changes help to support a slightly lower P/E assumption and a modestly stronger revenue growth outlook in the updated model.
Narratiefupdate • Mar 23
JEN: Higher P/E Confidence Will Support Appeal Despite Margin Reset
Analysts have raised their fair value estimate for Jenoptik from €32.00 to €33.00, reflecting updated assumptions on revenue growth, profit margins, and future P/E, as well as recent supportive Street research. Analyst Commentary Recent Street research points to a more constructive tone around Jenoptik, with bullish analysts highlighting factors they see as supportive of the revised €33.00 fair value estimate.Narratiefupdate • Mar 09
JEN: Fair Value View Will Rely On Margins And P/E Holding Firm
Analysts have raised their price target on Jenoptik from €25.56 to €28.50. They cite adjustments to fair value estimates, discount rate assumptions, revenue growth expectations, profit margin outlook and future P/E levels as the reasons for the change.Narratiefupdate • Feb 23
JEN: Future Returns Will Depend On Uncertain Margin And P/E Assumptions
Narrative Update on Jenoptik Analysts have lifted their fair value estimate for Jenoptik from €21.50 to €24.00. This reflects slightly adjusted assumptions around discount rates, revenue growth, profit margins and future P/E multiples in recent research updates.Analyseartikel • Feb 14
We Think Jenoptik (ETR:JEN) Is Taking Some Risk With Its Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Narratiefupdate • Feb 09
JEN: Upgraded Outlook Will Rely On Optimistic Margin And P/E Assumptions
Analysts have nudged their fair value target for Jenoptik slightly higher to €21.50, citing updated assumptions for discount rate, revenue growth, profit margin and future P/E that reflect the latest Deutsche Bank research upgrade and related Street analysis. Analyst Commentary Recent research points to a more cautious tone around Jenoptik, even with fair value estimates now centered around €21.50.Analyseartikel • Jan 29
Investors Appear Satisfied With Jenoptik AG's (ETR:JEN) Prospects As Shares Rocket 25%
Jenoptik AG ( ETR:JEN ) shareholders have had their patience rewarded with a 25% share price jump in the last month...Narratiefupdate • Jan 26
JEN: Multi Year Outlook Will Balance Leadership Transition And Earnings Multiple
Analysts have reaffirmed their price target on Jenoptik at €21.50, reflecting updated views on the company’s discount rate, revenue growth assumptions, profit margin outlook, and expected future P/E multiple. What's in the News Jenoptik's supervisory board announced that President & CEO Dr. Stefan Traeger will step down from the Executive Board on February 15, 2026, after nearly nine years in the role, and will leave Jenoptik AG by mutual agreement.Narratiefupdate • Jan 11
JEN: Higher Margin Outlook Will Support Appeal Despite Leadership Transition
Analysts have trimmed their fair value estimate for Jenoptik from €34.22 to €32.00, citing updated assumptions for slightly lower revenue growth, a higher profit margin and a reduced future P/E multiple. What's in the News The supervisory board announced that Dr. Stefan Traeger will step down from the Executive Board on February 15, 2026 and leave Jenoptik AG by mutual agreement after nearly nine years as President & CEO (Key Developments).Analyseartikel • Jan 03
What Does Jenoptik AG's (ETR:JEN) Share Price Indicate?
Jenoptik AG ( ETR:JEN ), is not the largest company out there, but it saw a double-digit share price rise of over 10...Narratiefupdate • Dec 26
JEN: Multi Year Revenue Outlook Will Support Stronger Future Earnings Multiple
Analysts have raised their price target on Jenoptik from €18.50 to €21.50, reflecting improved expectations for multi year revenue growth, slightly higher profit margins, and a richer future earnings multiple. What's in the News The supervisory board announced that President and CEO Dr. Stefan Traeger will step down from the Executive Board on February 15, 2026, and will leave Jenoptik AG by mutual agreement after nearly nine years in the role (company announcement) Valuation Changes The fair value estimate has risen moderately from €18.50 to €21.50, reflecting a more optimistic outlook on Jenoptik's intrinsic worth.Narratiefupdate • Dec 12
JEN: Stable Margins And Leadership Transition Will Support Future Upside Potential
Analysts have marginally increased their price target on Jenoptik to approximately $25.56. This reflects slightly higher assumptions for the company’s discount rate and future price to earnings multiple, while maintaining stable growth and margin expectations.Analyseartikel • Dec 01
An Intrinsic Calculation For Jenoptik AG (ETR:JEN) Suggests It's 49% Undervalued
Key Insights Using the 2 Stage Free Cash Flow to Equity, Jenoptik fair value estimate is €39.06 Jenoptik's €19.74 share...Narratiefupdate • Nov 27
JEN: Modest Profit Margin Increase Will Drive Upside Potential
Analysts have raised their price target on Jenoptik slightly, increasing it from €25.44 to €25.56. They cited refinements in their financial models based on modest improvements in the company’s valuation metrics and outlook.Narratiefupdate • Nov 13
JEN: Revenue Gains And Profit Margin Improvement Will Support Upside Potential
Analysts have increased their fair value estimate for Jenoptik from €24.46 to €25.44. This change reflects expectations of higher revenue growth and improved profit margins, even though the discount rate is slightly lower.Analyseartikel • Oct 04
Cautious Investors Not Rewarding Jenoptik AG's (ETR:JEN) Performance Completely
With a price-to-earnings (or "P/E") ratio of 14.3x Jenoptik AG ( ETR:JEN ) may be sending bullish signals at the...Narratiefupdate • Sep 12
Global Semiconductor Investment Will Advance Photonics And Mobility Expansion
The downward revision in Jenoptik’s consensus price target reflects softer revenue growth forecasts, with fair value decreasing from €25.12 to €24.46. What's in the News Jenoptik AG removed from Germany MDAX Index (Performance).Analyseartikel • Aug 30
An Intrinsic Calculation For Jenoptik AG (ETR:JEN) Suggests It's 49% Undervalued
Key Insights The projected fair value for Jenoptik is €33.48 based on 2 Stage Free Cash Flow to Equity Jenoptik's...Analyseartikel • Jul 23
Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analyseartikel • May 16
Jenoptik AG Just Missed EPS By 16%: Here's What Analysts Think Will Happen Next
It's been a good week for Jenoptik AG ( ETR:JEN ) shareholders, because the company has just released its latest...Analyseartikel • Apr 30
Jenoptik (ETR:JEN) Is Paying Out A Larger Dividend Than Last Year
Jenoptik AG ( ETR:JEN ) has announced that it will be increasing its dividend from last year's comparable payment on...Analyseartikel • Apr 20
Are Investors Undervaluing Jenoptik AG (ETR:JEN) By 34%?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Jenoptik fair value estimate is €24.74 Jenoptik's €16.45 share...Analyseartikel • Apr 05
Benign Growth For Jenoptik AG (ETR:JEN) Underpins Stock's 34% Plummet
Jenoptik AG ( ETR:JEN ) shareholders that were waiting for something to happen have been dealt a blow with a 34% share...Analyseartikel • Feb 27
At €23.20, Is Jenoptik AG (ETR:JEN) Worth Looking At Closely?
Jenoptik AG ( ETR:JEN ), might not be a large cap stock, but it saw a double-digit share price rise of over 10% in the...
Nieuw narratief • Feb 22
Investments In Dresden Facility And Diversification Will Support Future Performance
Strategic investments in semiconductor capacity and sales channels bolster future growth, helping offset market volatility and enhance revenue potential.Analyseartikel • Jan 13
Here's Why Jenoptik (ETR:JEN) Can Manage Its Debt Responsibly
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyseartikel • Nov 15
Earnings Beat: Jenoptik AG Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Jenoptik AG ( ETR:JEN ) shareholders are probably feeling a little disappointed, since its shares fell 3.2% to €21.82...Analyseartikel • Nov 14
Jenoptik AG's (ETR:JEN) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio
Jenoptik AG ( ETR:JEN ) shareholders that were waiting for something to happen have been dealt a blow with a 28% share...Analyseartikel • Oct 14
Is Jenoptik AG (ETR:JEN) Trading At A 47% Discount?
Key Insights The projected fair value for Jenoptik is €54.80 based on 2 Stage Free Cash Flow to Equity Current share...Analyseartikel • Sep 28
Is There Now An Opportunity In Jenoptik AG (ETR:JEN)?
While Jenoptik AG ( ETR:JEN ) might not have the largest market cap around , it saw a double-digit share price rise of...Analyseartikel • Aug 15
Market Participants Recognise Jenoptik AG's (ETR:JEN) Earnings
When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 17x, you may consider...Analyseartikel • Jun 12
Here's Why Shareholders May Want To Be Cautious With Increasing Jenoptik AG's (ETR:JEN) CEO Pay Packet
Key Insights Jenoptik will host its Annual General Meeting on 18th of June CEO Stefan Traeger's total compensation...Analyseartikel • May 30
Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Analyseartikel • Apr 25
Jenoptik (ETR:JEN) Will Pay A Larger Dividend Than Last Year At €0.35
The board of Jenoptik AG ( ETR:JEN ) has announced that it will be paying its dividend of €0.35 on the 21st of June, an...Analyseartikel • Apr 15
Jenoptik AG's (ETR:JEN) P/E Is On The Mark
When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 17x, you may consider...Analyseartikel • Mar 30
Jenoptik's (ETR:JEN) Upcoming Dividend Will Be Larger Than Last Year's
Jenoptik AG ( ETR:JEN ) has announced that it will be increasing its periodic dividend on the 21st of June to €0.35...Analyseartikel • Mar 22
At €30.04, Is Jenoptik AG (ETR:JEN) Worth Looking At Closely?
While Jenoptik AG ( ETR:JEN ) might not have the largest market cap around , it saw a double-digit share price rise of...Analyseartikel • Jan 07
Getting In Cheap On Jenoptik AG (ETR:JEN) Might Be Difficult
When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 16x, you may consider...Analyseartikel • Dec 20
Is Jenoptik (ETR:JEN) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyseartikel • Dec 05
Why Jenoptik AG (ETR:JEN) Could Be Worth Watching
While Jenoptik AG ( ETR:JEN ) might not be the most widely known stock at the moment, it saw a significant share price...Analyseartikel • Sep 01
Is It Too Late To Consider Buying Jenoptik AG (ETR:JEN)?
Jenoptik AG ( ETR:JEN ), might not be a large cap stock, but it saw significant share price movement during recent...Analyseartikel • Aug 11
Is There An Opportunity With Jenoptik AG's (ETR:JEN) 49% Undervaluation?
Key Insights The projected fair value for Jenoptik is €53.53 based on 2 Stage Free Cash Flow to Equity Jenoptik's...Analyseartikel • Jul 25
Jenoptik (ETR:JEN) Has A Pretty Healthy Balance Sheet
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyseartikel • May 07
Jenoptik (ETR:JEN) Will Pay A Larger Dividend Than Last Year At €0.30
Jenoptik AG ( ETR:JEN ) has announced that it will be increasing its dividend from last year's comparable payment on...Analyseartikel • Apr 04
We Think Jenoptik (ETR:JEN) Can Stay On Top Of Its Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyseartikel • Feb 19
Should You Think About Buying Jenoptik AG (ETR:JEN) Now?
Jenoptik AG ( ETR:JEN ), is not the largest company out there, but it received a lot of attention from a substantial...Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( €586.2M ) JEN } overtreffen de korte termijn passiva ( €256.1M ).
Langlopende schulden: De kortetermijnactiva JEN ( €586.2M ) overtreffen de langetermijnschulden ( €419.2M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: De netto schuld/eigen vermogen ratio ( 30.1% ) JEN wordt als voldoende beschouwd.
Schuld verminderen: De schuld/eigen vermogen-ratio van JEN is de afgelopen 5 jaar gedaald van 56.5% naar 38.2%.
Schuldendekking: De schuld van JEN wordt goed gedekt door de operationele kasstroom ( 44% ).
Rentedekking: De rentebetalingen op de schuld van JEN worden goed gedekt door EBIT ( 5.9 x dekking).
Balans
Ontdek gezonde bedrijven
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/05/22 23:17 |
| Aandelenkoers aan het einde van de dag | 2026/05/22 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Jenoptik AG wordt gevolgd door 18 analisten. 9 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Peter Rothenaicher | Baader Helvea Equity Research |
| Volker Bosse | Baader Helvea Equity Research |
| Lasse Stueben | Berenberg |